about
Blood groups - minuses and pluses. Do the blood group antigens protect us from infectious diseases?Construction of an agglutination tool: recombinant Fab fragments biotinylated in vitro.CD1: A Singed Cat of the Three Antigen Presentation Systems.A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokinesA single point mutation in the gene encoding Gb3/CD77 synthase causes a rare inherited polyagglutination syndrome.Studies of a murine monoclonal antibody directed against DARC: reappraisal of its specificity.The baculovirus-expressed binding region of Plasmodium falciparum EBA-140 ligand and its glycophorin C binding specificity.Evaluation of an amino acid residue critical for the specificity and activity of human Gb3/CD77 synthase.Multiple interests in structural models of DARC transmembrane protein.P1PK, GLOB, and FORS blood group systems and GLOB collection: biochemical and clinical aspects. Do we understand it all yet?Expression and binding properties of a soluble chimeric protein containing the N-terminal domain of the Duffy antigen.Human Gb3/CD77 synthase reveals specificity toward two or four different acceptors depending on amino acid at position 211, creating P(k), P1 and NOR blood group antigens.Can mutations in the gene encoding transcription factor EKLF (Erythroid Krüppel-Like Factor) protect us against infectious and parasitic diseases?Section 5: Structural/genetic analysis of mAbs to blood group antigens. Coordinator's report.Construction of dimeric F(ab) useful in blood group serology.Recombinant forms of glycophorin C as a tool for characterization of epitopes for new murine monoclonal antibodies with anti-glycophorin C specificity.Degradation of the human erythrocyte membrane band 3 studied with monoclonal antibody directed against an epitope on the cytoplasmic fragment of band 3.A monoclonal anti-glycophorin A antibody recognizing the blood group M determinant: studies on the subspecificity.Purification of a secreted form of recombinant rabies virus glycoprotein: comparison of two affinity tags.Plasmodium reichenowi EBA-140 merozoite ligand binds to glycophorin D on chimpanzee red blood cells, shedding new light on origins of Plasmodium falciparum.Mouse models of IgG- and IgM-mediated hemolysis.The Gerbich blood group system: old knowledge, new importance.RT-qPCR analysis of human melanoma progression-related genes - a novel workflow for selection and validation of candidate reference genes.Isolation of carcinoembryonic antigen N-terminal domains (N-A1) from soluble aggregates.Single nucleotide polymorphisms in A4GALT spur extra products of the human Gb3/CD77 synthase and underlie the P1PK blood group system.Phage display selection of P1 mutants of BPTI directed against five different serine proteinasesRecombinant forms of Gerbich blood group antigens: expression and purificationThe role of MMP-12 gene polymorphism - 82 A-to-G (rs2276109) in immunopathology of COPD in polish patients: a case control studyIdentification of an epitope recognized by the monoclonal antibody PEP80 in the C-terminal cytoplasmic fragment of glycophorin AMonoclonal antibodies against band 3 proteinAn immunoblotting procedure for screening glycophorins and band 3 protein in the same blots. Identification of glycophorin and band 3 variant formsBiochemical characterization of the O-glycans on recombinant glycophorin A expressed in Chinese hamster ovary cellsMapping of peptidic epitopes of glycophorins A (GPA) and C (GPC) with peptides synthesized on plastic pins (Pepscan analysis)Shared epitopes of glycoprotein A and protein 4.1 defined by antibody NaM10-3C10Mutational analysis of the N-glycosylation sites of Duffy antigen/receptor for chemokinesHigh-resolution melting analysis for genotyping Duffy blood group antigensDuffy blood group system - the frequency of Duffy antigen polymorphisms and novel mutations in the Polish population
P50
Q26799970-C4F06109-B4D2-4544-B6F2-D600CBCFDCA2Q33510837-D19C7E86-52D3-4458-A0FF-4BD25C3100ECQ33695019-496FD070-C3AF-4BFC-BCB9-5D01A6DD8941Q34254934-369F709C-77DA-4FF8-8B29-0A8951768990Q34410704-C3D53D59-D9F1-4DEB-A790-8BD4DEEBD77BQ35112490-6F1DD7B9-281D-417A-971A-864E2D750989Q35542746-C2564D82-177F-464F-82AA-A7264E58F5B2Q37491643-83F451D8-4ACD-411C-B973-F16CBAA1CECAQ37775257-F247A87B-D55F-4BAA-9814-0D6BB2D3C29AQ38217465-9AA79815-9A3F-4110-86B8-51BA691DF88DQ38310880-96EE6684-3292-44E9-AF37-45EC386E59A7Q38803078-A97BD072-7A39-4995-8B65-93B331749B16Q40515628-45866A69-4139-4396-A9E3-C03211E42A35Q40745191-CCD58345-9B53-4049-BD5B-B50213C6AAD4Q43918925-9730E16F-C4D3-41F0-908C-47BDDC906955Q43975607-6B38B890-0AE8-41A8-A8C7-ED5C54A81D28Q45256802-2008AFEC-D7B9-4C72-8B65-B004988754BAQ45263736-EB1407E8-6445-410F-B2CF-6B819A1468C6Q45768130-7E074A4E-E693-4D05-BE34-121CE8E16C5EQ46505307-49117633-9D88-45A0-A73A-3A233F775ED0Q50714235-86E29D6D-356B-43DD-B917-F3CABABC6BA2Q52655600-66C8127B-5754-40F0-8084-EA4F02A8FA8BQ54108642-CE05C9E5-E2BD-4749-98D4-64EEFEAD24EFQ54364117-B0C47881-FEB9-45B2-882F-737E43A4178EQ55047205-9521470C-E25C-46C5-A336-2F69C2CB0C06Q56896698-98DA8E65-D510-4B26-990C-628F624A866DQ57208553-E8218990-9E22-48FD-80C6-CB2361B720B5Q61446294-D7A25EE3-FAA8-48BE-AE15-F8365069B739Q67537632-2CF3C184-D1F2-4B01-9C11-F9C2D5840112Q70238178-CA3DABB3-1604-4F9E-9EEB-46E945D6C770Q70625524-8E9616C2-89FB-4EC4-9881-BD6399ED54D8Q72455875-79AE21B7-96D9-4151-9A07-5634821430F8Q73206710-3020511E-2E46-4F48-B81D-18A118F26E6EQ77109101-06A4E9E4-D84B-4C7E-ACE3-43D1BE73BDEEQ80027784-B6CC60BD-970C-4E7F-8A6D-8830600F90D1Q85257243-E5E880B5-2A96-4900-AE06-5F0117D2ACE4Q91028690-56C93999-F61E-4514-B13C-7BD8DC54A9E8
P50
description
researcher ORCID ID = 0000-0003-2859-3699
@en
wetenschapper
@nl
name
Marcin Czerwinski
@ast
Marcin Czerwinski
@en
Marcin Czerwinski
@es
Marcin Czerwinski
@nl
type
label
Marcin Czerwinski
@ast
Marcin Czerwinski
@en
Marcin Czerwinski
@es
Marcin Czerwinski
@nl
prefLabel
Marcin Czerwinski
@ast
Marcin Czerwinski
@en
Marcin Czerwinski
@es
Marcin Czerwinski
@nl
P106
P108
P1153
7005748467
P31
P496
0000-0003-2859-3699